Ezetimibe-Loaded Nanostructured Lipid Carrier for Oral Delivery: Response Surface Methodology; In Vitro Characterization and Assessing the Antihyperlipidemic Effect in Rats. [PDF]
Elkhayat D +3 more
europepmc +1 more source
Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases.
Swartz AZ +4 more
europepmc +1 more source
Alternative therapeutic approach of ovine subclinical mastitis using the ethanolic roots extract of <i>Capparis spinosa</i>. [PDF]
Wahab BAA +3 more
europepmc +1 more source
Washed Microbiota Transplantation Is Associated With Improved Lipid Profiles: Long-Term Efficacy and Safety in an Observational Cohort From South China. [PDF]
Liang F +6 more
europepmc +1 more source
Biological Activities and Phytochemical Screening of <i>Thuja occidentalis</i> Extracts with In Silico Approaches. [PDF]
Younes K +8 more
europepmc +1 more source
Metabolomic Profiling of Taiwanese Roselle (<i>Hibiscus sabdariffa</i>) Leaves and Their Antiproliferative and Insulin Resistance-Ameliorating Potential. [PDF]
Liao YH +4 more
europepmc +1 more source
Contemporary Speculations and Insightful Thoughts on Buckwheat-A Functional Pseudocereal as a Smart Biologically Active Supplement. [PDF]
Kurćubić VS +7 more
europepmc +1 more source
In Utero/Childhood/ Adolescence Exposure to Tobacco Smoke and Elderly-Onset Cataract: A Large Prospective Cohort Study. [PDF]
Lai C +9 more
europepmc +1 more source
Related searches:
Antihyperlipidemia Activity of Sygyzium Polyanthum Ethanol Extract on Benzene Induced Rats
2021 IEEE International Conference on Health, Instrumentation & Measurement, and Natural Sciences (InHeNce), 2021Hyperlipidemia is a significant risk factor for cardiovascular events, especially included cerebrovascular, coronary, and peripheral artery disease. Meanwhile, benzene is toxic at 500 parts per million and lethal at 20,000 parts per million for 5 to 10 minutes.
Ali Napiah Nasution, Sukirman Lie
exaly +2 more sources
Rheumatic manifestations of hyperlipidemia and antihyperlipidemia drug therapy
Seminars in Arthritis and Rheumatism, 1993Conflicting data exist with respect to the existence and clinical manifestations of a hyperlipidemic arthropathy. Reasonable evidence supports the existence of a migratory polyarthritis similar to rheumatic fever in patients homozygous for type II hyperlipidemia.
M G Cohen
exaly +3 more sources

